Cargando…

Management of no Reflow during Percutaneous Transcoronary Angioplasty with Catheter-Directed Intracoronary Thrombolysis: A Retrospective Observational Study

BACKGROUND: Intracoronary thrombus is common in patients with ST-elevation myocardial infarction (STEMI). Percutaneous coronary intervention (PCI) is the treatment of choice for these patients. Intracoronary thrombus is still a challenge during PCI in STEMI, even with dual antiplatelets, glycoprotei...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Rakendra, Singla, Sanjeev Kumar, Singla, Ankush, Manchanda, Surbhi, Kaur, Manjot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886142/
https://www.ncbi.nlm.nih.gov/pubmed/36726658
http://dx.doi.org/10.4103/ijabmr.ijabmr_407_22
_version_ 1784880074178166784
author Singh, Rakendra
Singla, Sanjeev Kumar
Singla, Ankush
Manchanda, Surbhi
Kaur, Manjot
author_facet Singh, Rakendra
Singla, Sanjeev Kumar
Singla, Ankush
Manchanda, Surbhi
Kaur, Manjot
author_sort Singh, Rakendra
collection PubMed
description BACKGROUND: Intracoronary thrombus is common in patients with ST-elevation myocardial infarction (STEMI). Percutaneous coronary intervention (PCI) is the treatment of choice for these patients. Intracoronary thrombus is still a challenge during PCI in STEMI, even with dual antiplatelets, glycoprotein IIb/IIIa inhibitor, and anticoagulation. Intracoronary thrombus can cause distal or nonculprit vessel embolization and no-reflow state. No reflow results in large infarct size, adverse left ventricular remodeling, arrhythmias, and death. Recently, catheter-directed intracoronary thrombolysis (ICT) is gaining acceptance in patients with no-reflow due to a large thrombus burden. AIM: Evaluation of catheter-directed ICT in patients with acute STEMI who develop no reflow due to large thrombus burden during PCI. MATERIALS AND METHODS AND RESULTS: This was a retrospective observational study conducted after approval of the institutional ethics committee in a tertiary care hospital of north India from April 15, 2021 to April 14, 2022, included 1020 adult patients who had undergone coronary evaluation. 37.25% patients had PCI, among these 10% had PCI for acute STEMI. Thrombolysis in myocardial infarction (TIMI) Grade 5 in 79.17% and Grade 4 in 20.83%. ICT was done with low-dose tenecteplase (15 ± 5 mg). The TIMI flow III in 91.67% and II in 8.33% of patients was achieved after intracoronary thrombolysis. Major risk factor was tobacco smoking in 41.67%, and the major complication was left ventricular failure in 33.33%. CONCLUSIONS: Catheter-directed ICT is safe and effective in reducing thrombus burden, thus improving myocardial reperfusion in STEMI. This condition has a grave prognosis and can lead to adverse cardiac outcomes. There are many drugs that have been tried to manage no reflow. The use of ICT to treat no-reflow state can be life saving with minimal systemic side effects.
format Online
Article
Text
id pubmed-9886142
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-98861422023-01-31 Management of no Reflow during Percutaneous Transcoronary Angioplasty with Catheter-Directed Intracoronary Thrombolysis: A Retrospective Observational Study Singh, Rakendra Singla, Sanjeev Kumar Singla, Ankush Manchanda, Surbhi Kaur, Manjot Int J Appl Basic Med Res Original Article BACKGROUND: Intracoronary thrombus is common in patients with ST-elevation myocardial infarction (STEMI). Percutaneous coronary intervention (PCI) is the treatment of choice for these patients. Intracoronary thrombus is still a challenge during PCI in STEMI, even with dual antiplatelets, glycoprotein IIb/IIIa inhibitor, and anticoagulation. Intracoronary thrombus can cause distal or nonculprit vessel embolization and no-reflow state. No reflow results in large infarct size, adverse left ventricular remodeling, arrhythmias, and death. Recently, catheter-directed intracoronary thrombolysis (ICT) is gaining acceptance in patients with no-reflow due to a large thrombus burden. AIM: Evaluation of catheter-directed ICT in patients with acute STEMI who develop no reflow due to large thrombus burden during PCI. MATERIALS AND METHODS AND RESULTS: This was a retrospective observational study conducted after approval of the institutional ethics committee in a tertiary care hospital of north India from April 15, 2021 to April 14, 2022, included 1020 adult patients who had undergone coronary evaluation. 37.25% patients had PCI, among these 10% had PCI for acute STEMI. Thrombolysis in myocardial infarction (TIMI) Grade 5 in 79.17% and Grade 4 in 20.83%. ICT was done with low-dose tenecteplase (15 ± 5 mg). The TIMI flow III in 91.67% and II in 8.33% of patients was achieved after intracoronary thrombolysis. Major risk factor was tobacco smoking in 41.67%, and the major complication was left ventricular failure in 33.33%. CONCLUSIONS: Catheter-directed ICT is safe and effective in reducing thrombus burden, thus improving myocardial reperfusion in STEMI. This condition has a grave prognosis and can lead to adverse cardiac outcomes. There are many drugs that have been tried to manage no reflow. The use of ICT to treat no-reflow state can be life saving with minimal systemic side effects. Wolters Kluwer - Medknow 2022 2022-12-19 /pmc/articles/PMC9886142/ /pubmed/36726658 http://dx.doi.org/10.4103/ijabmr.ijabmr_407_22 Text en Copyright: © 2022 International Journal of Applied and Basic Medical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Singh, Rakendra
Singla, Sanjeev Kumar
Singla, Ankush
Manchanda, Surbhi
Kaur, Manjot
Management of no Reflow during Percutaneous Transcoronary Angioplasty with Catheter-Directed Intracoronary Thrombolysis: A Retrospective Observational Study
title Management of no Reflow during Percutaneous Transcoronary Angioplasty with Catheter-Directed Intracoronary Thrombolysis: A Retrospective Observational Study
title_full Management of no Reflow during Percutaneous Transcoronary Angioplasty with Catheter-Directed Intracoronary Thrombolysis: A Retrospective Observational Study
title_fullStr Management of no Reflow during Percutaneous Transcoronary Angioplasty with Catheter-Directed Intracoronary Thrombolysis: A Retrospective Observational Study
title_full_unstemmed Management of no Reflow during Percutaneous Transcoronary Angioplasty with Catheter-Directed Intracoronary Thrombolysis: A Retrospective Observational Study
title_short Management of no Reflow during Percutaneous Transcoronary Angioplasty with Catheter-Directed Intracoronary Thrombolysis: A Retrospective Observational Study
title_sort management of no reflow during percutaneous transcoronary angioplasty with catheter-directed intracoronary thrombolysis: a retrospective observational study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886142/
https://www.ncbi.nlm.nih.gov/pubmed/36726658
http://dx.doi.org/10.4103/ijabmr.ijabmr_407_22
work_keys_str_mv AT singhrakendra managementofnoreflowduringpercutaneoustranscoronaryangioplastywithcatheterdirectedintracoronarythrombolysisaretrospectiveobservationalstudy
AT singlasanjeevkumar managementofnoreflowduringpercutaneoustranscoronaryangioplastywithcatheterdirectedintracoronarythrombolysisaretrospectiveobservationalstudy
AT singlaankush managementofnoreflowduringpercutaneoustranscoronaryangioplastywithcatheterdirectedintracoronarythrombolysisaretrospectiveobservationalstudy
AT manchandasurbhi managementofnoreflowduringpercutaneoustranscoronaryangioplastywithcatheterdirectedintracoronarythrombolysisaretrospectiveobservationalstudy
AT kaurmanjot managementofnoreflowduringpercutaneoustranscoronaryangioplastywithcatheterdirectedintracoronarythrombolysisaretrospectiveobservationalstudy